# [Tick-Borne Diseases in Dogs](/knowledge/parasites/pet-parasites/tick-borne-diseases-dogs-pathogen-list-curability-management): Clinical Syndromes and Diagnostic Approaches
## Key Takeaways
- Canine tick-borne diseases manifest with overlapping clinical syndromes such as fever, thrombocytopenia, anemia, and multi-organ dysfunction, necessitating a systematic diagnostic approach integrating signalment, geographic history, and laboratory findings.
- *Ehrlichia canis* causes monocytic ehrlichiosis with a triphasic course, leading to fever, lymphadenomegaly, and thrombocytopenia in the acute phase, potentially progressing to pancytopenia and immune-mediated bone marrow suppression in chronic stages.
- *Babesia* spp. infections are characterized by hemolytic anemia and hemoglobinuria, with severity varying between large (*B. canis*) and small (*B. gibsoni*) species, and can progress to systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction syndrome (MODS).
- Diagnostic modalities range from hematology and blood smear examination for morulae and piroplasms to serologic methods (IFA, ELISA) for antibody detection (requiring 7-14 days post-infection) and highly sensitive molecular techniques like PCR and RT-PCR for direct pathogen DNA/RNA detection.
- Emerging pathogens such as SFTS virus (Bandavirus dabieense) pose a significant zoonotic risk, presenting with acute febrile illness, profound thrombocytopenia, leukopenia, and elevated liver enzymes, with dogs acting as sentinel hosts and viral RNA detectable in blood, urine, and tissues.
- A hierarchical diagnostic workflow, commencing with CBC and blood smear, followed by targeted PCR or serology, and potentially incorporating broad-range molecular assays and emerging technologies like metagenomic sequencing, is crucial for accurate diagnosis and effective management.
---
[Canine tick-borne diseases](/knowledge/parasites/pet-parasites/canine-tick-borne-diseases-lyme-ehrlichiosis-anaplasmosis-babesiosis) represent a complex group of vector-borne infections that manifest with overlapping clinical syndromes, making accurate diagnosis essential for effective management. These diseases are caused by obligate intracellular bacteria, protozoan parasites, and viruses transmitted primarily through hard ticks (Ixodidae) and, less commonly, soft ticks (Argasidae) [1]. The clinical presentation often involves fever, thrombocytopenia, anemia, and multi-organ dysfunction, yet the specific etiologic agent determines the pathophysiologic trajectory and required therapeutic intervention [2, 3]. This article provides a comprehensive reference for veterinary clinicians and diagnostic pathologists, detailing the major tick-borne pathogens affecting dogs, their associated clinical syndromes, and the contemporary diagnostic modalities available.
## Major Pathogens and Clinical Syndromes
### Ehrlichiosis ([Ehrlichia canis](/knowledge/bacteria/pet-bacteria/ehrlichia-canis) and Ehrlichia ewingii)
[Canine monocytic ehrlichiosis](/knowledge/bacteria/pet-bacteria/ehrlichia-canis-monocytic-ehrlichiosis-dogs-tick-thrombocytopenia), caused by *[Ehrlichia canis](/knowledge/bacteria/pet-bacteria/ehrlichia-canis)*, is a globally distributed disease transmitted primarily by *Rhipicephalus sanguineus* (the brown dog tick) [4]. The pathogen infects monocytes and macrophages, leading to a triphasic clinical course: acute, subclinical, and chronic. Acute phase signs include fever, depression, lymphadenomegaly, and thrombocytopenia [4]. Chronic infection can result in pancytopenia, epistaxis, and secondary infections due to immune-mediated bone marrow suppression. *Ehrlichia ewingii*, in contrast, predominantly infects granulocytes and tends to cause a milder, non-febrile polyarthritis, though thrombocytopenia remains a consistent finding [3]. Coinfections with *Anaplasma platys* and *Ehrlichia canis* have been documented, particularly in tropical regions, and these coinfections often exacerbate the clinicopathologic abnormalities [5]. Biomarkers such as erythrocyte sedimentation rate, C-reactive protein, and interleukin-6 are elevated in naturally infected dogs and may serve as adjunctive inflammatory indicators [6].
### Anaplasmosis (Anaplasma platys and [Anaplasma phagocytophilum](/knowledge/bacteria/livestock-bacteria/anaplasma-phagocytophilum-equine-granulocytic-anaplasmosis-tick))
*Anaplasma platys* infects platelets, causing cyclic thrombocytopenia in dogs [5]. The clinical syndrome is often subclinical, but severe cases may present with petechiation, epistaxis, and prolonged bleeding times. *[Anaplasma phagocytophilum](/knowledge/bacteria/livestock-bacteria/anaplasma-phagocytophilum-equine-granulocytic-anaplasmosis-tick)*, the agent of granulocytic anaplasmosis, is less commonly reported in dogs but can cause acute febrile illness with lethargy, anorexia, and polyarthritis [7]. Both species are members of the family Anaplasmataceae and are transmitted by ixodid ticks [7, 8]. Diagnosis relies on detection of morulae within infected cells on blood smear or via molecular techniques.
### Babesiosis (Babesia canis and Babesia gibsoni)
Canine babesiosis is a protozoal disease caused by large (e.g., *Babesia canis*) and small (e.g., *Babesia gibsoni*) piroplasms. *Babesia canis* infection produces hemolytic anemia, hemoglobinuria, fever, and splenomegaly, with severity influenced by the geographic strain and host immune status [9, 10]. In southeastern Romania, *Babesia canis* has been reported as a frequent cause of clinical disease in dogs with outdoor access [11]. The hallmark of babesiosis is hemolytic anemia, which may progress to systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction syndrome (MODS). Plasma biomarkers of SIRS and MODS, including eicosanoids and lipids, are significantly altered in infected dogs, reflecting the inflammatory response [12, 13]. Large *Babesia* species infections are often associated with more severe hematological alterations and higher mortality than infections with small species [9].
### Hepatozoonosis ([Hepatozoon canis](/knowledge/parasites/pet-parasites/hepatozoon-canis-dogs-tick-ingestion-diagnosis))
Canine hepatozoonosis differs from other tick-borne diseases because transmission occurs not through tick saliva but through ingestion of an infected tick or tick parts containing oocysts [14]. *[Hepatozoon canis](/knowledge/parasites/pet-parasites/hepatozoon-canis-dogs-tick-ingestion-diagnosis)* infects mononuclear cells and causes a chronic, debilitating syndrome characterized by fever, muscle atrophy, periosteal bone proliferation, and neutrophilic leukocytosis [14]. The disease is most common in the Mediterranean basin and tropical regions. Diagnosis is frequently made by detecting gamonts in blood smears or by histologic examination of skeletal muscle.
### Rickettsiosis (Rickettsia species)
*Rickettsia rickettsii*, the agent of Rocky Mountain spotted fever, is a significant cause of systemic vasculitis in dogs, characterized by fever, edema of the face and extremities, and petechial hemorrhages [15]. Other spotted fever group rickettsiae, such as *Rickettsia parkeri* detected in *Amblyomma maculatum* ticks feeding on dogs in Mexico, may also cause febrile illness in dogs, though the clinical spectrum is less well defined [15]. Rickettsial infections often present acutely and require prompt anti-rickettsial therapy.
### Severe Fever with Thrombocytopenia Syndrome (SFTS) Virus
SFTS virus (Bandavirus dabieense) is an emerging tick-borne virus that causes severe illness in dogs and humans [2, 16]. The virus is transmitted by *Rhipicephalus sanguineus* and other tick species, and dogs can act as sentinel hosts [17, 18]. Clinical signs in naturally infected dogs include acute febrile illness, profound thrombocytopenia, leukopenia, and elevated liver enzymes [2]. Multisystem involvement and multiorgan failure have been reported in fatal cases, with unusual cutaneous manifestations sometimes observed [17]. The virus has been detected in multiple body systems and excreted in urine, indicating potential for environmental contamination [19]. Companion animals in endemic regions of Korea and Thailand have shown seroprevalence and active infection, underscoring the one health importance of this pathogen [20, 21]. In Thailand, molecular evidence has linked dog-associated ticks to fatal human SFTSV infections, confirming the zoonotic potential [16, 22].
### Other and Coinfections
Dogs may present with coinfections involving multiple tick-borne pathogens, complicating the clinical picture. For example, simultaneous infection with *Ehrlichia canis*, *Anaplasma platys*, and *Nocardia otitidiscaviarum* has been described, leading to pleural effusion and severe systemic illness [5]. In some cases, tick toxicosis caused by the bite of *Ornithodoros brasiliensis* can mimic infectious disease through the action of toxins in tick saliva, producing acute paralysis and hematological abnormalities [1]. Additionally, emerging pathogens such as *Candidatus* Neoehrlichia mikurensis have been detected in canids and may contribute to unexplained febrile syndromes [7].
## Diagnostic Approaches
The clinical overlap among tick-borne diseases necessitates a systematic diagnostic approach that integrates signalment, geographic exposure history, physical examination findings, and a sequence of laboratory tests. Table 1 summarizes the key diagnostic features of the major pathogens.
**Table 1. Summary of major canine tick-borne pathogens and associated clinical and diagnostic features**
| Pathogen | Primary Target Cell | Key Clinical Signs | Preferred Diagnostic Method | Typical Hematologic Finding |
|-----|-----------|----------|--------------|---------------|
| *Ehrlichia canis* | Monocyte/macrophage | Fever, epistaxis, lymphadenopathy | Serology (IFA, ELISA), PCR | Thrombocytopenia, pancytopenia |
| *Ehrlichia ewingii* | Granulocyte | Polyarthritis, lameness | PCR on blood or joint fluid | Mild thrombocytopenia |
| *Anaplasma platys* | Platelet | Cyclic thrombocytopenia, petechiae | Blood smear (morulae), PCR | Cyclic thrombocytopenia |
| *[Anaplasma phagocytophilum](/knowledge/bacteria/livestock-bacteria/anaplasma-phagocytophilum-equine-granulocytic-anaplasmosis-tick)* | Granulocyte | Fever, lethargy, polyarthritis | PCR, serology | Thrombocytopenia |
| *Babesia canis* | Erythrocyte | Hemolytic anemia, hemoglobinuria | Blood smear, PCR | Anemia, thrombocytopenia |
| *[Hepatozoon canis](/knowledge/parasites/pet-parasites/hepatozoon-canis-dogs-tick-ingestion-diagnosis)* | Mononuclear cell | Muscle atrophy, periosteal bone proliferation | Blood smear (gamonts), histology | Neutrophilic leukocytosis |
| SFTS virus (Bandavirus dabieense) | Leukocyte, megakaryocyte | Fever, thrombocytopenia, liver enzyme elevation | RT-PCR, serology | Thrombocytopenia, leukopenia |
| *Rickettsia rickettsii* | Vascular endothelium | Fever, edema, petechiae | Serology (IFA), immunohistochemistry, PCR | Thrombocytopenia |
### Hematology and Blood Smear Examination
Complete blood count (CBC) with manual examination of stained blood smears remains a fundamental first step. An automated impedance analyzer can detect abnormalities in platelet count, hemoglobin concentration, and white blood cell differential, but manual smear examination is essential for identifying morulae (e.g., *Ehrlichia canis* in monocytes, *Anaplasma platys* in platelets, *[Anaplasma phagocytophilum](/knowledge/bacteria/livestock-bacteria/anaplasma-phagocytophilum-equine-granulocytic-anaplasmosis-tick)* in neutrophils) and intra-erythrocytic piroplasms (Babesia spp.) [5, 9]. Thrombocytopenia is a nearly universal finding across acute tick-borne infections, whereas anemia distinguishes babesiosis from most rickettsial diseases [6, 9]. In chronic ehrlichiosis, pancytopenia may be observed [4].
### Acute Phase Protein and Biomarker Analysis
Serum markers of inflammation can provide supportive evidence. Dogs infected with *Ehrlichia canis* exhibit elevated C-reactive protein and interleukin-6 concentrations, which correlate with disease severity [6]. In babesiosis, eicosanoid profiles and serum lipids shift, reflecting arachidonic acid metabolism activation [13]. The quantification of these biomarkers can aid in monitoring response to therapy and in distinguishing between acute and chronic disease.
### Serologic Methods
Detection of antibodies by indirect [immunofluorescence assay](/knowledge/diagnostics/molecular/immunofluorescence-assay) (IFA) or enzyme-linked immunosorbent assay (ELISA) is widely used for pathogens such as *Ehrlichia canis*, *Anaplasma* spp., and *Rickettsia rickettsii* [15, 18, 20]. Seroconversion requires 7-14 days post-infection, limiting the utility of serology for acute diagnosis. In SFTS virus infection, Ig M and Ig G antibody detection can confirm exposure, especially in serosurveillance studies [20, 21]. A positive serologic result in a dog with compatible clinical signs is highly suggestive of active or recent infection.
### Molecular Diagnostics
Nucleic acid amplification tests (NAATs) offer high sensitivity and specificity for the direct detection of pathogen DNA or RNA. Conventional polymerase chain reaction (PCR) and quantitative real-time PCR are available for *Ehrlichia* spp., *Anaplasma* spp., *Babesia* spp., *Hepatozoon* spp., *Rickettsia* spp., and SFTS virus [2, 3, 10, 19]. Real-time PCR assays can be multiplexed to detect multiple targets in a single reaction. A novel syndromic molecular assay using barcoded magnetic bead technology has been developed that can simultaneously detect *Ehrlichia canis*, *Anaplasma platys*, *Babesia vogeli*, and other pathogens, providing a rapid, high-throughput screening tool for endemic regions [23]. For SFTS virus, [reverse transcription PCR](/knowledge/diagnostics/molecular/reverse-transcription-pcr-principles-protocol-cdna-synthesis) (RT-PCR) targeting the L, M, or S segments is the gold standard for confirming acute infection, and viral RNA can be detected in blood, urine, and tissues [16, 17, 19].
### Diagnostic Decision Workflow
The following flowchart illustrates a systematic approach to the diagnosis of [tick-borne diseases in dogs](/knowledge/parasites/pet-parasites/tick-borne-diseases-dogs-treatment-diagnosis).
```mermaid
flowchart TD
A["Canine patient with fever, thrombocytopenia, or lameness"] --> B["Tick exposure history?"]
B -- No --> C["Consider other infectious or immune-mediated diseases"]
B -- Yes --> D["Perform CBC & blood smear"]
D --> E{"Morulae or piroplasms seen?"}
E -- Yes --> F["Targeted PCR or serology for suspected pathogen"]
E -- No --> G["Acute phase serology + broad-range PCR"]
G --> H{"Positive result?"}
H -- Yes --> I["Treat based on identified pathogen"]
H -- No --> J["Repeat serology in 2-3 weeks if suspected recent infection"]
J --> K{"Seroconversion?"}
K -- Yes --> I
K -- No --> L["Consider less common agents: Hepatozoon, Neoehrlichia, SFTSV"]
L --> M["Specialized PCR or RT-PCR for rare pathogens"]
M --> N{"Positive?"}
N -- Yes --> I
N -- No --> O["Alternative diagnosis"]
```
The workflow emphasizes that even in the absence of visible pathogens on blood smear, broad molecular testing should be pursued in endemic areas to capture acute and low-burden infections.
### Emerging Diagnostics and Surveillance
Metagenomic next-generation sequencing (mNGS) is being increasingly applied to veterinary diagnostics for the unbiased detection of tick-borne pathogens. Although yet to be fully commercialized for routine use, mNGS can identify coinfections and novel variants without the need for a priori selection of targets. For SFTS virus, genomic and phylogenetic characterization of viral strains circulating in companion animals provides data for vaccine development and risk assessment [20, 21]. Additionally, long-term shedding of SFTS virus in canine urine as detected by isolation and RT-PCR illustrates the importance of diagnostic monitoring in potentially infected animals to prevent zoonotic transmission [19].
## Conclusion
[Canine tick-borne diseases](/knowledge/parasites/pet-parasites/canine-tick-borne-diseases-lyme-ehrlichiosis-anaplasmosis-babesiosis) present a diagnostic challenge due to their overlapping clinical syndromes and the diversity of etiologic agents. A hierarchical diagnostic approach that begins with thorough clinical assessment and hematologic evaluation, proceeds through targeted serology and molecular testing, and incorporates emerging technologies such as syndromic bead-based assays and next-generation sequencing, is essential for accurate identification. Increasing awareness of emerging pathogens like SFTS virus, combined with rigorous one health surveillance, will improve both canine and human health outcomes in endemic regions [16, 21]. The integration of cost-effective, point-of-care molecular tests into routine practice is expected to further enhance the speed and accuracy of diagnosis.
***
## Related Clinical & Scientific Guides
* [Tick-Borne Diseases in Dogs: Pathogens, Clinical Signs, Diagnosis, and Prevention](/knowledge/parasites/general/tick-borne-diseases-dogs)
* [Toxoplasmosis in Cats and the Risk of Brain Infection in Humans](/knowledge/parasites/general/toxoplasmosis-cats-brain-infection-humans)
* [Dog Heartworm and Tick-Borne Disease Prevention](/knowledge/parasites/general/dog-heartworm-and-tick-borne-disease-prevention)